Most Read Articles
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Pearl Toh, 6 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Elvira Manzano, 17 Nov 2020
Invasive fungal infections, particularly those caused by Candida species, are common in hospitalized, immunocompromised, or critically ill patients and are associated with considerable morbidity and mortality.

Glucose-lowering drugs pose no risk of severe hyponatremia

16 Apr 2020

Use of glucose-lowering medications appears to have neutral effects on the risk of hospitalization due to severe hyponatraemia, with a recent study even showing an inverse association across all investigated drugs.

The study involved 14,359 hospitalized patients with hyponatraemia and 57,383 matched controls without the condition. The median age of the overall population was 76 years, and 72 percent were women.

More patients than controls had been recently dispensed a glucose-lowering medication (10.1 percent vs 7.5 percent).  The most frequently prescribed were metformin (n=3,027), insulin (n=2,510) and sulfonylureas (n=1,359).

In unadjusted logistic regression models, the use of glucose-lowering medications was associated with a higher risk of hospitalization due to hyponatraemia compared with nonuse. The odds ratios (ORs) were 1.41 (95 percent confidence interval [CI], 1.29–1.54) with insulins, 1.38 (95 percent CI, 1.27–1.50) with metformin and 1.22 (95 percent CI, 1.07–1.38) with sulfonylureas.

However, on multivariable analysis that controlled for confounding factors, the association was consistently reversed. The adjusted ORs for hospitalization due to hyponatraemia was 0.63 (95 percent CI, 0.58–0.68) with any glucose-lowering medication, 0.58 (95 percent CI, 0.52–0.65) with insulins, 0.81 (95 percent CI, 0.72–0.90) with metformin and 0.81 (95 percent CI, 0.69–0.94) with sulfonylureas.

The estimates for newly initiated medications were generally higher, whereas those for ongoing treatment were further decreased. The adjusted ORs associated with ongoing treatment with insulins, metformin and sulfonylureas were 0.54 (95 percent CI, 0.48–0.61), 0.82 (95 percent CI, 0.73–0.91) and 0.78 (95 percent CI, 0.66–0.92), respectively.

Researchers pointed out that pharmacologic mechanisms may have mediated the associations observed, but the uniform effects across drug-classes suggest that properties of the diabetic disease are of importance.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Pearl Toh, 6 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Elvira Manzano, 17 Nov 2020
Invasive fungal infections, particularly those caused by Candida species, are common in hospitalized, immunocompromised, or critically ill patients and are associated with considerable morbidity and mortality.